Components of the plasminogen activation system (PAS) which are overexpressed in aggressive breast cancer subtypes offer appealing targets for development of new diagnostics and therapeutics. molecular target for breast cancer. The development of human recombinant anti-uPAR antagonistic antibodies, by panning a fragment-antigen binding (Fab) phage display library against recombinant human uPAR, has been previously AC220… Continue reading Components of the plasminogen activation system (PAS) which are overexpressed in